IDCQ HOSPITALES Y SANIDAD SL

Their core work

Quirónsalud is Spain's largest private hospital group, operating dozens of hospitals and healthcare centres across the country. In H2020 projects, they contribute real-world clinical data, patient cohorts, and hospital infrastructure for validating AI-driven healthcare tools. Their role spans clinical trials for cardiac risk prediction, prostate cancer imaging AI, and big data platforms for elderly care. They serve as a clinical validation partner, bridging the gap between research prototypes and actual hospital deployment.

What they specialise in

How they've shifted over time

Quirónsalud entered H2020 in 2019 with a focus on big data analytics and connected health for elderly independent living (SMART BEAR). By 2020, their involvement shifted decisively toward AI-powered clinical tools — both in cardiology (PROFID's sudden cardiac death prediction) and oncology (ProCAncer-I's prostate cancer imaging AI). The trajectory shows a clear move from general health data platforms toward disease-specific AI clinical decision support.

Quirónsalud is increasingly positioning itself as a clinical validation site for disease-specific AI tools, suggesting future interest in projects that need real hospital environments to test AI diagnostics and risk prediction systems.

How they like to work

Quirónsalud participates exclusively as a partner, never as coordinator — consistent with a large hospital group contributing clinical expertise rather than managing research. With 85 unique partners across just 3 projects, they operate in very large consortia (averaging ~28 partners each), typical of major EU health innovation actions. This makes them an accessible partner — experienced in large multi-national teams and comfortable in complex consortium structures.

Quirónsalud has built connections with 85 distinct partners across 20 countries through only 3 projects, reflecting involvement in large-scale European health consortia. Their network is broadly pan-European with no visible geographic concentration beyond Spain.

What sets them apart

Quirónsalud brings something most research partners cannot: a massive operational hospital network with real patients, real clinical workflows, and real deployment environments. For any project that needs to move an AI health tool from the lab to the bedside, having Spain's largest private healthcare provider in the consortium adds immediate clinical credibility and a pathway to real-world piloting. Their private-sector status also means faster decision-making compared to public hospital bureaucracies.

Highlights from their portfolio

• ProCAncer-I
  Ambitious AI platform for prostate cancer integrating imaging repositories, cloud infrastructure, and advanced AI — combines oncology with large-scale data engineering.
• PROFID
  Directly addresses sudden cardiac death prevention with a personalised clinical decision tool — high potential for real clinical impact post-myocardial infarction.